You are viewing an inactive listing
This listing is not currently recruiting Study Participants on If you would like to find active listings please search here

New York, New York

  • Adult Male Hypogonadism


This is a Phase 3 clinical trial in adult hypogonadal males with baseline serum testosterone concentrations <300 ng/dL. The purpose of this study is to evaluate the safety and efficacy of testosterone gel (2%) delivered using an applicator.


Inclusion Criteria: 1. Males between 18-75 years of age 2. Two screening serum testosterone values less than 300 ng/dL 3. One or more symptoms of testosterone deficiency Exclusion Criteria: 1. Previous use of the investigational product 2. Use of any investigational product within 30 days prior to screening and during the study 3. BMI less than 18 kg/m^2 or more than 35 kg/m^2 4. Prostatic mass(es) 5. Generalized skin irritation or skin disease 6. Lower urinary tract obstruction 7. Myocardial infarction or cerebrovascular accident in the last 6 months 8. Unstable angina or congestive heart failure 9. Thromboembolic disorders 10. Sleep apnea 11. Hyperparathyroidism or uncontrolled diabetes 12. Untreated moderate to severe depression 13. History of testicular, prostate, or breast cancer 14. HIV, Hepatitis B, or Hepatitis C positive 15. PSA more or equal to 3 ng/mL 16. Use of any medications that could be considered anabolic 17. Use of estrogens, Gonadotropin Releasing Hormone agonists/antagonists, antiandrogens, or human Growth Hormone 18. Chronic use of any drug of abuse 19. Involvement in a sport in which there is a screening for anabolic steroids 20. Not willing to use adequate contraception during the study 21. Partner is pregnant and/or breast feeding 22. Partner has a history of breast, uterine or ovarian cancer



Primary Contact:

Study Director
Clinical Development Support
Ferring Pharmaceuticals

Backup Contact:


Location Contact:

New York, New York
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: August 02, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.